Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Good cardiac safety in patients with relapsing remitting multiple sclerosis upon first fingolimod dose.
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
[The application of high-frequency and iTBS transcranial magnetic stimulation for the treatment of spasticity in the patients presenting with secondary progressive multiple sclerosis].
Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Effects of vitamin D on the peripheral adaptive immune system: a review.
The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome.
Similar Effects Seen for Fingolimod, Placebo in Primary Progressive Multiple Sclerosis
Neurological findings in incontinentia pigmenti; a review.
Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specific.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Thoracic sensory level as a false localizing sign in cervical spinal cord and brain lesions.
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Polymorphisms of Immunoglobulin G Fc Receptors in Pediatric Guillain-Barré Syndrome.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
Splenic Marginal Zone Lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Cavernous angioma: a clinical study of 35 cases with review of the literature.
Emerging Role of P2X7 Receptors in CNS Health and Disease.
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls.
Pages
« first
‹ previous
…
681
682
683
684
685
686
687
688
689
…
next ›
last »